Evidence map›Paper›PMID 33706755›Full record

ArticleDiagnostic pathology2021

Diagnosis prediction of tumours of unknown origin using ImmunoGenius, a machine learning-based expert system for immunohistochemistry profile interpretation.

Yosep Chong, Nishant Thakur, Ji Young Lee, Gyoyeon Hwang, Myungjin Choi, Yejin Kim, Hwanjo Yu, Mee Yon Cho

Open access · goldAbstract read
In one paragraph

Article in Diagnostic pathology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Yosep ChongDepartment of Hospital Pathology, College of Medicine, The Catholic University of Korea, 271, Cheonbo-ro, Uijeongbu, 11765, Gyeonggi-do, Republic of Korea. ychong@catholic.ac.kr.ORCID http://orcid.org/0000-0001-8615-3064
Nishant ThakurDepartment of Hospital Pathology, College of Medicine, The Catholic University of Korea, 271, Cheonbo-ro, Uijeongbu, 11765, Gyeonggi-do, Republic of Korea.
Ji Young LeeDepartment of Hospital Pathology, College of Medicine, The Catholic University of Korea, 271, Cheonbo-ro, Uijeongbu, 11765, Gyeonggi-do, Republic of Korea.
Gyoyeon HwangDepartment of Hospital Pathology, College of Medicine, The Catholic University of Korea, 271, Cheonbo-ro, Uijeongbu, 11765, Gyeonggi-do, Republic of Korea.
Myungjin ChoiDasom X, Inc., Seoul, Republic of Korea.
Yejin KimDepartment of Creative Information Technology, POSTECH, Pohang, Republic of Korea.
Hwanjo YuComputer Science and Engineering, POSTECH, Pohang, Republic of Korea.
Mee Yon ChoDepartment of Pathology, Yonsei University, Wonju College of Medicine, Wonju, Republic of Korea.
Catholic University of Korea · KRPohang University of Science and Technology · KRThe Catholic University of Korea Uijeongbu St. Mary's Hospital · KRYonsei University · KR

Funding

National Research Foundation of Korea (NRF) funded by the Ministry of Education 2016R1D1A1A02937427Po-Ca Networking Groups funded by the Postech-Catholic Biomedical Engineering Institute (PCBMI). No 5-2016-B0001-00149
6 · The paper itself

Abstract

backgroundImmunohistochemistry (IHC) remains the gold standard for the diagnosis of pathological diseases. This technique has been supporting pathologists in making precise decisions regarding differential diagnosis and subtyping, and in creating personalized treatment plans. However, the interpretation of IHC results presents challenges in complicated cases. Furthermore, rapidly increasing amounts of IHC data are making it even harder for pathologists to reach to definitive conclusions.

methodsWe developed ImmunoGenius, a machine-learning-based expert system for the pathologist, to support the diagnosis of tumors of unknown origin. Based on Bayesian theorem, the most probable diagnoses can be drawn by calculating the probabilities of the IHC results in each disease. We prepared IHC profile data of 584 antibodies in 2009 neoplasms based on the relevant textbooks. We developed the reactive native mobile application for iOS and Android platform that can provide 10 most possible differential diagnoses based on the IHC input.

resultsWe trained the software using 562 real case data, validated it with 382 case data, tested it with 164 case data and compared the precision hit rate. Precision hit rate was 78.5, 78.0 and 89.0% in training, validation and test dataset respectively. Which showed no significant difference. The main reason for discordant precision was lack of disease-specific IHC markers and overlapping IHC profiles observed in similar diseases.

conclusionThe results of this study showed a potential that the machine-learning algorithm based expert system can support the pathologic diagnosis by providing second opinion on IHC interpretation based on IHC database. Incorporation with contextual data including the clinical and histological findings might be required to elaborate the system in the future.

Indexed as

ImmunohistochemistryMachine LearningAlgorithmsBayes TheoremExpert SystemsHumansNeoplasmsSoftwareDatabaseExpert systemImmunohistochemistryMachine learningProbabilistic decision tree

Identifiers

PMID33706755
PMCPMC7953791
OpenAlexW3125117623

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.